logo

For the Inventor, By the Inventor

Urawa, Japan

Mikio Takeda

USPTO Granted Patents = 11

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 96(Granted Patents)


Location History:

  • Urawa, JA (1976)
  • Urawa, JP (1982 - 1989)

Company Filing History:

goldMedal11 out of 324 
 
Tanabe Seiyaku Company, Limited
 patents

Years Active: 1976-1989

Loading Chart...
11 patents (USPTO):Explore Patents
1. 4886817 - Imidazolidinones as brain activators (1989-12-12),
2. 4665068 - Novel 9-chloro-1,5-benzothiazepine derivatives and their pharmaceutical (1987-05-12),
3. 4594342 - 1,5-benzothiazepine derivative (1986-06-10),
4. 4590188 - 1,5-benzothiazepine derivatives and their pharmaceutical use (1986-05-20),
5. 4585768 - 1,5-benzothiazepine derivatives and processes for preparing the same (1986-04-29),
6. 4567175 - 8-Chloro-1,5-benzothiazepine derivatives (1986-01-28),
7. 4521430 - 1,5-Benzothiazepin-4-one, their pharmaceutical compositoins, and methods (1985-06-04),
8. 4472573 - Nitrosourea derivative and process for preparing same (1984-09-18),
9. 4404214 - 2-Pyridinecarboxamide derivatives compositions containing same and (1983-09-13),
10. 4332809 - Pyridinecarboxamide derivatives and process for the preparation thereof (1982-06-01),
11. 3932429 - Novel azabicyclo octane derivative and process for preparing same (1976-01-13),

Title: Mikio Takeda: Innovator in Pharmaceutical Chemistry

Introduction

Mikio Takeda is a prominent inventor based in Urawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Takeda has developed imidazolidinones as brain activators. This invention relates to imidazolidinone compounds that can enhance cognitive function. Another notable patent is for novel 9-chloro-1,5-benzothiazepine derivatives, which are useful as hypotensive agents and cerebral or coronary vasodilators. These compounds have the potential to improve cardiovascular health and brain function.

Career Highlights

Mikio Takeda is currently associated with Tanabe Seiyaku Company, Limited, where he continues to innovate in the pharmaceutical sector. His extensive research and development efforts have led to advancements in drug formulations and therapeutic agents.

Collaborations

Throughout his career, Takeda has collaborated with notable colleagues, including Tokuro Oh-ishi and Hiromichi Nakajima. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Mikio Takeda's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to improving health outcomes through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…